Tomokatsu Hongo

Lumitek Corp. is engaged in the manufacturing and servicing of light emitting diode chip. It provides wafer dicing services which includes grinding, laser scribing, probing, sorting and PI. The company was founded in June 2004 and is headquartered in Hsinchu, Taiwan.

Rakuten Capital is the venture capital division of Rakuten Inc. and is headquartered in Tokyo, Japan. The firm was founded in 2014 by Rakuten Inc.

CTY Ventures engages in the provision of investment advisory services. The company was founded on December 11, 2013 and is headquartered in Taipei, Taiwan.

Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto.

EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then.

APB Corp. supplies and produces lithium-ion batteries. The company was founded by Hideaki Horie in October 2018 and is headquartered in Tokyo, Japan.

Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune.

LIFESCAPES, Inc. is a company based in Tokyo, Japan that combines brain science and AI to develop BMIs that connect the brain and machine. The Japanese company's goal is to bring out the "healing force" of the brain and provide rehabilitation for severe paralysis after stroke. The company aims to spread and support the patient's hope.

HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021.